| Product Code: ETC7638450 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ireland Preventable Vaccines Market Overview |
3.1 Ireland Country Macro Economic Indicators |
3.2 Ireland Preventable Vaccines Market Revenues & Volume, 2021 & 2031F |
3.3 Ireland Preventable Vaccines Market - Industry Life Cycle |
3.4 Ireland Preventable Vaccines Market - Porter's Five Forces |
3.5 Ireland Preventable Vaccines Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.6 Ireland Preventable Vaccines Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.7 Ireland Preventable Vaccines Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Ireland Preventable Vaccines Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.9 Ireland Preventable Vaccines Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Ireland Preventable Vaccines Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the importance of vaccination in Ireland |
4.2.2 Government initiatives to promote preventive healthcare measures |
4.2.3 Rising prevalence of infectious diseases in the region |
4.3 Market Restraints |
4.3.1 Vaccine hesitancy among certain segments of the population |
4.3.2 High costs associated with vaccine development and distribution |
4.3.3 Regulatory challenges and stringent approval processes |
5 Ireland Preventable Vaccines Market Trends |
6 Ireland Preventable Vaccines Market, By Types |
6.1 Ireland Preventable Vaccines Market, By Technology |
6.1.1 Overview and Analysis |
6.1.2 Ireland Preventable Vaccines Market Revenues & Volume, By Technology, 2021- 2031F |
6.1.3 Ireland Preventable Vaccines Market Revenues & Volume, By Inactivated Vaccines, 2021- 2031F |
6.1.4 Ireland Preventable Vaccines Market Revenues & Volume, By Live Attenuated Vaccines, 2021- 2031F |
6.1.5 Ireland Preventable Vaccines Market Revenues & Volume, By Toxoid Vaccines, 2021- 2031F |
6.1.6 Ireland Preventable Vaccines Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Ireland Preventable Vaccines Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 Ireland Preventable Vaccines Market Revenues & Volume, By Pneumococcal Disease, 2021- 2031F |
6.2.3 Ireland Preventable Vaccines Market Revenues & Volume, By Influenza, 2021- 2031F |
6.2.4 Ireland Preventable Vaccines Market Revenues & Volume, By Polio, 2021- 2031F |
6.2.5 Ireland Preventable Vaccines Market Revenues & Volume, By Hepatitis, 2021- 2031F |
6.2.6 Ireland Preventable Vaccines Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Ireland Preventable Vaccines Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Ireland Preventable Vaccines Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 Ireland Preventable Vaccines Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.4 Ireland Preventable Vaccines Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Ireland Preventable Vaccines Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Ireland Preventable Vaccines Market Revenues & Volume, By Homecare, 2021- 2031F |
6.4.4 Ireland Preventable Vaccines Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.4.5 Ireland Preventable Vaccines Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Ireland Preventable Vaccines Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Ireland Preventable Vaccines Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.5.3 Ireland Preventable Vaccines Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.5.4 Ireland Preventable Vaccines Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
7 Ireland Preventable Vaccines Market Import-Export Trade Statistics |
7.1 Ireland Preventable Vaccines Market Export to Major Countries |
7.2 Ireland Preventable Vaccines Market Imports from Major Countries |
8 Ireland Preventable Vaccines Market Key Performance Indicators |
8.1 Immunization coverage rates among different age groups in Ireland |
8.2 Number of public health campaigns promoting vaccination awareness |
8.3 Research and development investments in new vaccines for preventable diseases |
8.4 Rate of vaccine uptake in vulnerable populations |
8.5 Number of reported cases of preventable diseases in Ireland |
9 Ireland Preventable Vaccines Market - Opportunity Assessment |
9.1 Ireland Preventable Vaccines Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.2 Ireland Preventable Vaccines Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.3 Ireland Preventable Vaccines Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Ireland Preventable Vaccines Market Opportunity Assessment, By End User, 2021 & 2031F |
9.5 Ireland Preventable Vaccines Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Ireland Preventable Vaccines Market - Competitive Landscape |
10.1 Ireland Preventable Vaccines Market Revenue Share, By Companies, 2024 |
10.2 Ireland Preventable Vaccines Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here